ICs	Immune checkpoints
ICIs	Immune checkpoint inhibitors
γδ T	Gamma delta T
αβ T	Alpha beta T
NK	Natural killer
TCR	T cell receptor
MHC	Major histocompatibility complex
HIV	Human Immunodeficiency virus
EBV	Epstein–Barr virus
HBV	Hepatitis B virus
IFN-g	Interferon-gamma
TNF-α	Tumor necrosis factor-alpha
IL	Interleukin
Ab	Antibody
PhAg	Phosphoantigen
ITIMs	Immunoreceptor tyrosine-based inhibition motifs
HLA	Human leukocyte antigen
TILs	Tumor infiltrating lymphocytes
CRC	Colorectal carcinoma
CLL	Chronic lymphocytic leukemia
AML	Acute myeloid leukemia
GBM	Glioblastoma
CRLM	Liver metastastic colorectal carcinoma
HCC	Hepatocellular carcinoma
OC	Ovarian cancer
IELs	Intraepithelial lymphocytes
ADCC	Antibody-dependent cellular cytotoxicity
BTN/BTNs	Butyrophilin family/Butyrophilins
GvHD	Graft versus Host Disease
CARs	Chimeric antigen receptors
BiTEs	Bispecific T cell engagers
ABP	Aminobisphosphonate
MM	Multiple myeloma
NHL	Non-Hodgkin lymphoma
RCC	Renal cell carcinoma
ALL	Acute lymphoblastic leukemia
NSCLC	Non-small cell lung cancer
TME	Tumor microenvironment
OS	Overall survival
HCMV	Human Cytomegalovirus
mAb	Monoclonal antibody
EGFR	Epidermal growth factor receptor
HNSCC	Head and neck squamous cell carcinoma